<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Resistance to chemotherapy is a major obstacle for the success of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> therapy and is most commonly attributed to the inability of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> cells to die by <z:mpath ids='MPATH_3'>apoptosis</z:mpath>, the archetypal programed cell <z:hpo ids='HP_0011420'>death</z:hpo> (PCD) response </plain></SENT>
<SENT sid="1" pm="."><plain>The development of anticancer drugs that can overcome this resistance to <z:mpath ids='MPATH_3'>apoptosis</z:mpath> and induce other forms of cell <z:hpo ids='HP_0011420'>death</z:hpo> is therefore paramount for efficient <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> therapy </plain></SENT>
<SENT sid="2" pm="."><plain>We report that the antidepressants maprotiline and <z:chebi fb="0" ids="5118">fluoxetine</z:chebi> induce autophagic PCD in the chemoresistant Burkitt's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e>) cell line DG-75, which does not involve caspases, DNA fragmentation or PARP cleavage, but is associated with the development of cytoplasmic vacuoles, <z:hpo ids='HP_0000001'>all</z:hpo> consistent with an autophagic mode of PCD </plain></SENT>
<SENT sid="3" pm="."><plain>Autophagic PCD was confirmed by transmission electron microscopy, upregulation of Beclin-I and the extent of PCD being reduced by the autophagic inhibitor 3-MA </plain></SENT>
<SENT sid="4" pm="."><plain>In contrast, these compounds induced apoptotic PCD in the biopsy-like chemosensitive <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e> MUTU-I cell line </plain></SENT>
<SENT sid="5" pm="."><plain>We provide evidence that the chemoresistant DG-75 cells do not express the proapoptotic Bcl-2 proteins Bax and Bak, show diminished levels of stored intracellular calcium and display shortened rod-like mitochondria, <z:hpo ids='HP_0000001'>all</z:hpo> of which are known to be associated with a defective "apoptotic" response in <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> cells </plain></SENT>
<SENT sid="6" pm="."><plain>PCD in the two cell lines has different Ca(2+) responses to maprotiline and <z:chebi fb="0" ids="5118">fluoxetine</z:chebi>, which may also account for their differential PCD responses </plain></SENT>
<SENT sid="7" pm="."><plain>Our study, therefore, supports a new mechanistic role for maprotiline and <z:chebi fb="0" ids="5118">fluoxetine</z:chebi> as novel proautophagic agents in the treatment of resistant <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e>, and thus an alternative therapeutic application for these compounds </plain></SENT>
</text></document>